Overcoming the challenges of immunosenescence in the prevention of acute respiratory illness in older people

Connecticut Medicine

Volumn 67, Issue 8, 2003, Pages 469-474

  McElhaney, Janet E ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b MC 1601   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

ABDOMINAL PAIN; ACUTE RESPIRATORY TRACT DISEASE; AGED; AGING; AMNESIA; ANTIVIRAL ACTIVITY; BRONCHOSPASM; CHRONIC DISEASE; CONFUSION; COST BENEFIT ANALYSIS; COST CONTROL; DIAGNOSTIC VALUE; DIARRHEA; DRUG EFFICACY; DRUG MECHANISM; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HIGH RISK PATIENT; HUMAN; IMMUNOSENESCENCE; IMMUNOSTIMULATION; INFLUENZA; INSOMNIA; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LUNG DISEASE; MORBIDITY; NAUSEA; NEUROTOXICITY; PHYSICAL DISABILITY; PRIMARY PREVENTION; REACTION OPTIMIZATION; REVIEW; SENESCENCE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VACCINATION; VERTIGO; VIRUS INFECTION; VOMITING;

AGED; AGING; ANTIVIRAL AGENTS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; RESPIRATORY TRACT INFECTIONS; VACCINATION; VIRUS DISEASES;

EID: 0141669252     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Ferrucci L, Guralnik JM, Pahor M, et al: Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled [see comments]. JAMA 1997; 277:728-34.
2. Barker WH: Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health 1986; 76:761-5.
3. Williams WW, Hickson MA, Kane MA, et al: Immunization policies and vaccine coverage among adults. The risk for missed opportunities [published erratum appears in Ann Intern Med 1988 15; 109(4):348]. Ann Intern Med 1988; 108:616-25.
4. Thompson WW, Shay DK, Weintraub E, et al: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
5. Gravenstein S, Davidson HE: Current strategies for management of influenza in the elderly population. Clin Infect Dis 2002; 35:729-37.
6. Falsey AR, Cunningham CK, Barker WH, et al: Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995; 172:389-94.
7. Cate TR: Impact of influenza and other community-acquired viruses. Semin Respir Infect 1998; 13:17-23.
8. Falsey AR, Walsh EE: Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000; 13:371-84.
9. Walsh EE, Falsey AR, Hennessey PA: Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med 1999; 160:791-5.
10. CDR: Seasonal increase in RSV as influenza activity remains at low levels. Commun Dis Rep CDR Wkly 2000; 10:457,460.
11. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T: The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community [see comments]. N Engl J Med 1994; 331:778-84.
12. Mullooly JP, Bennett MD, Hornbrook MC, et al: Influenza vaccination programs for elderly persons: Cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121:947-52
13. Gross PA, Hermogenes AW, Sacks HS, et al: The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123:518-27.
14. Glezen WP, Greenberg SB, Atmar RL, et al: Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000;283:499-505.
15. Hak E, Verheij TJ, van Essen GA, et al: Prognostic factors for influenza-associated hospitalization and death during an epidemic. Epidemiol Infect 2001; 126:261-8.
16. Nichol KL, Nordin J, Mullooly J, et al: Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348:1322-32.
17. Vu T, Farish S, Jenkins M, Kelly H: A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002; 20:1831-6.
18. Neuzil KM, O'Connor TZ, Gorse GJ, Nichol KL: Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine. Clin Infect Dis 2003; 36:169-74
19. Govaert TM, Sprenger MJ, Dinant GJ, et al: Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine 1994; 12:1185-9.
20. Palladino G, Scherle PA, Gerhard W: Activity of CD4+ T-cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitro. J Virol 1991; 65:6071-6.
21. Allen JE, Maizels RM: Th1-Th2: Reliable paradigm or dangerous dogma? [see comments]. Immunol Today 1997; 18:387-92.
22. Dong L, Mori I, Hossain MJ, Kimura Y: The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection. J Infect Dis 2000; 182:391-6.
23. Baumgarth N, Kelso A: In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol 1996; 70:4411-8.
24. Graham MB, Braciale VL, Braciale TJ: Influenza virus-specific CD4+ T helper type 2T lymphocytes do not promote recovery from experimental virus infection. J Exp Med 1994; 180:1273-82.
25. Doherty PC, Topham DJ, Tripp RA, et al: Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 1997; 159:105-17.
26. Powers DC: Influenza A virus-specific cytotoxic T lymphocyte activity declines with advancing age [see comments]. J Am Geriatr Soc 1993;41:1-5.
27. McElhaney JE, Upshaw CM, Hooton JW, et al: Responses to influenza vaccination in different T-cell subsets: A comparison of healthy young and older adults. Vaccine 1998; 16:1742-7.
28. Bernstein ED, Gardner EM, Abrutyn E, et al: Cytokine production after influenza vaccination in a healthy elderly population. Vaccine 1998; 16:1722-31.
29. Johnson BJ, Costelloe EO, Fitzpatrick DR, et al: Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Proc Natl Acad Sci USA 2003; 100:2657-62.
30. McElhaney JE, Gravenstein S, Upshaw CM, et al: Granzyme B: A marker of risk for influenza in institutionalized older adults. Vaccine 2001; 19:3744-51.
31. McElhaney JE, Herre JM, Cole SK, Hooton JW: Effect of congestive heart failure on the immune responses to influenza vaccination. 42th Interscience Conference on Amtimicrobial Agents and Chemotherapy, San Diego; September 2002.
32. Letter C, Gravenstein S, McElhaney JE: Influenza vaccination is less effective for stimulating a granzyme B response in older adults. Elsevier Science B.V. Int Congr Series 2001; 1219:713-21.
33. Gorse GJ, O'Connor TZ, Young SL, et al: Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: A VA cooperative study. Vaccine 2003; 21:2142-53.
34. Rothberg MB, Bellantonio S, Rose DN: Management of influenza in adults older than 65 years of age: Cost-effectivness of rapid testing and antiviral therapy. Ann Intern Med 2003; 139:321-9.
35. Bowles SK, Lee W, Simor AE, et al: Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. J Am Geriatr Soc 2002; 50:608-16.
36. Lee C, Loeb M, Phillips A, et al: Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home. Infect Control Hosp Epidemiol 2000; 21:700-4.
37. McGeer A: Oseltamivir was safe and effective for prophylaxis of influenza in the frail elderly. ACP J Club 2002; 136:24.
38. Peters PH, Jr., Gravenstein S, Norwood P, et al: Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001; 49:1025-31.
39. McElhaney JE, Gravenstein S, Cole SK, et al: A placebo-controlled trial of a proprietary extract of North American Ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults. J Am Geriatr Soc In Press.